AA: alopecia areata RANK: receptor activator of nuclear factor kappa RANKL: receptor activator of nuclear factor kappa b ligand TNF: tumor necrosis factor INTRODUCTION In the last 2 decades, various biologic agents have been developed to treat autoimmune disorders. Along with their high clinical efficacy, these agents have been associated with several paradoxical proinflammatory or autoimmune r...

OBJECTIVE To provide family physicians with a background understanding of the therapeutic regimens and treatment outcomes for alopecia areata (AA), as well as to help identify those patients for whom dermatologist referral might be required. SOURCES OF INFORMATION PubMed was searched for relevant articles regarding the treatment of AA. MAIN MESSAGE Alopecia areata is a form of autoimmune ha...

Discoid Lupus Erythematosus is usually localized on the open areas. On scalp it causes dilatation and plugging of hair follicles with adherent scales, this leads to destruction permanent alopecia. Initial manifestation disease can be difficult recognize. Early visit Dermatologist recommended. Differential diagnosis scarring alopecia include trauma, burn, tinea capitis, lichen planus, psoriasis,...

PURPOSE Evaluate the safety and effectiveness of bimatoprost 0.03% for treatment of eyelash hypotrichosis in a pediatric population. PATIENTS AND METHODS This multicenter, randomized, double-masked, parallel-group study was conducted at seven sites in the US and Brazil. Subjects with eyelash hypotrichosis caused by chemotherapy or alopecia areata (aged 5-17 years) or healthy adolescents aged ...

Background: Latanoprost, a prostaglandin F 2a analogue, is an intraocular pressure lowering drug used in the treatment of glaucoma. Increase in eyelash number, length, pigmentation, curvature is reported after using topical Latanoprost in these patients. The aim of this study was to evaluate the effect of Latanoprost ophthalmic solution on eyelash regrowth in patients with alopecia areata.Metho...